Warwick Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
984
-35
-3% -$12K 0.04% 103
2026
Q1
$359K Buy
1,019
+36
+4% +$12.8K 0.05% 95
2025
Q4
$322K Buy
983
+81
+9% +$25.7K 0.05% 108
2025
Q3
$255K Sell
902
-4
-0.4% -$1.16K 0.04% 129
2025
Q2
$253K Sell
906
-49
-5% -$13.9K 0.05% 103
2025
Q1
$298K Buy
955
+171
+22% +$50.5K 0.06% 91
2024
Q4
$204K Buy
784
+1
+0.1% +$297 0.04% 95
2024
Q3
$252K Buy
783
+3
+0.4% +$981 0.06% 81
2024
Q2
$244K Buy
+780
New +$229K 0.06% 91

Other funds holding AMGN

Warwick Investment Management's AMGN Position: Q2 2026 in Review

Warwick Investment Management reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $12K and leaving 984 shares worth $356K. The position accounts for 0.04% of the portfolio, ranked #103.

Warwick Investment Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $359K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Warwick Investment Management held 984 shares of Amgen worth $356K as of Q2 2026.
  • Warwick Investment Management sold 35 Amgen shares in Q2 2026, an estimated $12K.
  • Amgen made up 0.04% of Warwick Investment Management's portfolio in Q2 2026, its #103 holding.
  • Warwick Investment Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Warwick Investment Management's Amgen position peaked at $359K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Warwick Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.